Transcatheter Aortic Valve Replacement in a Patient With Criss-Cross Heart

Daniel Lewin1,2, Karel M Van Praet1,3, Gaik Nersesian1,3

  • 1Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.

JACC. Case Reports
|August 8, 2022
PubMed

Insights

This study details the first transcatheter treatment for severe aortic regurgitation in a patient with criss-cross heart disease. The minimally invasive procedure successfully eliminated regurgitation, significantly improving the patient's physical health.

Area of Science:

  • Cardiology
  • Congenital Heart Disease
  • Interventional Cardiology

Background:

  • Severe aortic regurgitation poses significant risks.
  • Criss-cross heart is an extremely rare and complex congenital heart anomaly.
  • Transcatheter aortic valve replacement (TAVR) is an evolving treatment option.